BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8225697)

  • 1. A non-invasive evaluation of flosequinan on haemodynamics and exercise capacity in chronic congestive heart failure.
    Motro M; Freimark D; Feinberg MS; Wynne RD; King C; Schneeweiss A
    Int J Clin Pharmacol Res; 1993; 13(3):143-9. PubMed ID: 8225697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flosequinan induces hemodynamic improvement in heart failure complicating acute myocardial infarction.
    Schneeweiss A; Marmor A; Wynne RD
    Herz; 1988 Aug; 13(4):259-62. PubMed ID: 3169679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of flosequinan on exercise capacity and cardiac function in patients with chronic mild heart failure: a double-blind placebo-controlled study.
    Hori M; Sato H; Ozaki H; Inoue M; Naka M; Fukunami M; Fukushima M; Kunisada K
    Heart Vessels; 1992; 7(3):133-40. PubMed ID: 1500398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First clinical trial with etomoxir in patients with chronic congestive heart failure.
    Schmidt-Schweda S; Holubarsch C
    Clin Sci (Lond); 2000 Jul; 99(1):27-35. PubMed ID: 10887055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of flosequinan on exercise capacity and symptoms in severe heart failure.
    Elborn JS; Stanford CF; Nicholls DP
    Br Heart J; 1989 Apr; 61(4):331-5. PubMed ID: 2653391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic effects of flosequinan on resting and exercise haemodynamics in congestive heart failure.
    Thomas P; O'Gorman DJ; Sheridan DJ
    Br J Clin Pharmacol; 1993 Dec; 36(6):539-46. PubMed ID: 12959270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise training in patients with severe chronic heart failure: impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Training Trial.
    Erbs S; Linke A; Gielen S; Fiehn E; Walther C; Yu J; Adams V; Schuler G; Hambrecht R
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):336-44. PubMed ID: 14663295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
    Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
    Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of increase of cardiac index during exercise in the chronic phase of various cardiovascular diseases: evaluation by exercise tolerance and brain natriuretic peptide].
    Omiya K; Tanabe K; Samejima H; Suzuki N; Yokoyama Y; Yamamoto A; Nakayama M; Osada N; Yamamoto M; Itoh H; Murayama M
    J Cardiol; 1997 Mar; 29(3):149-56. PubMed ID: 9095445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of assessing changes in ventricular response to atrial fibrillation during evaluation of new heart failure therapies: experience from trials of flosequinan.
    Massie BM; Shah NB; Pitt B; Packer M
    Am Heart J; 1996 Jul; 132(1 Pt 1):130-6. PubMed ID: 8701855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study.
    Packer M; Narahara KA; Elkayam U; Sullivan JM; Pearle DL; Massie BM; Creager MA
    J Am Coll Cardiol; 1993 Jul; 22(1):65-72. PubMed ID: 8509565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
    Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
    J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors.
    Gottlieb SS; Kukin ML; Penn J; Fisher ML; Cines M; Medina N; Yushak M; Taylor M; Packer M
    J Am Coll Cardiol; 1993 Oct; 22(4):963-7. PubMed ID: 8409070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, parallel-group comparison of flosequinan and enalapril in the treatment of chronic heart failure.
    Silke B; Tennet H; Fischer-Hansen J; Keller N; Heikkila J; Salminen K
    Eur Heart J; 1992 Aug; 13(8):1092-100. PubMed ID: 1505560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
    Inage T; Yoshida T; Hiraki T; Ohe M; Takeuchi T; Nagamoto Y; Fukuda Y; Gondo T; Imaizumi T
    Europace; 2008 Mar; 10(3):379-83. PubMed ID: 18227354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of enalapril on cardiac arrhythmias in patients with congestive heart failure.
    Sniezek-Maciejewska M; Czarnecka D; Mroczek-Czernecka D; Kawecka-Jaszcz K
    Cor Vasa; 1992; 34(5-6):382-9. PubMed ID: 1285055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.